Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healthy hearts measured: new baseline for MRI scans

NCT ID NCT01712581

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to find normal values for heart tissue measurements using MRI in 175 healthy volunteers aged 18-69. By establishing these baselines, doctors can better detect abnormalities like scarring or iron buildup in future patients. No treatment or intervention was given—only observation and measurement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

175 people

The number who actually took part.

Start date

Aug 2012

Finished

Feb 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 69 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Volunteers over the age of 18 and less than 70 * Volunteers able to understand and sign the consent and to give written informed consent * Female contraceptives if of childbearing age * Registered or entitled to social security system * Volunteers able to maintain supine for 20 minutes Exclusion Criteria: * Major protected/under guardianship * Volunteers unable to maintain the supine position for 20 minutes * Claustrophobia * Volunteers with history of PRBC transfusion * Volunteers with history of hematologic disease or a disruption of iron status * Volunteers with history of cardiac disease including arrhythmias * Hypertension * Diabetes * Contra-indication for MRI: metal fragments in the eyes; implantable cardiac, neurological or ENT device; osteosynhesis material not compatible with MRI * Women who are pregnant or likely to be

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Normal myocardial T1, T2 and T2* values are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Normal myocardial T1, T2 and T2* values

Contacts and locations

Locations

  • Rouen University Hospital

    Rouen, 76031, France